Harmine targets inhibitor of DNA binding‐2 and activator protein‐1 to promote preosteoclast PDGF‐BB production

Osteoporosis is one of the most common metabolic bone diseases affecting millions of people. We previously found that harmine prevents bone loss in ovariectomized mice via increasing preosteoclast platelet‐derived growth factor‐BB (PDGF‐BB) production and type H vessel formation. However, the molecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jie, Li, You‐You, Xia, Kun, Wang, Yi‐Yi, Chen, Chun‐Yuan, Chen, Meng‐Lu, Cao, Jia, Liu, Zheng‐Zhao, Wang, Zhen‐Xing, Yin, Hao, Hu, Xiong‐Ke, Wang, Zheng‐Guang, Zhou, Yong, Xie, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184727/
https://www.ncbi.nlm.nih.gov/pubmed/33960660
http://dx.doi.org/10.1111/jcmm.16562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184727/
https://www.ncbi.nlm.nih.gov/pubmed/33960660
http://dx.doi.org/10.1111/jcmm.16562

Ejemplares similares